Traumatic Brain Injury
& Post Concussion
In the United Kingdom, 1.4 million people attend emergency departments in England and Wales for traumatic brain injury (TBI). TBI is one the primary cause of death and disability. TBI cases are classed as mild in 70-90 percent of cases, and up to 25% of them will not recover and experience permanent neurocognitive deficits.
Traumatic Brain Injury
Between 33% and 50% of these are children aged under 15 years. Annually, about 200,000 people are admitted to hospital with head injury. Of these, one-fifth have features suggesting skull fracture or have evidence of brain damage. Recent research has found that hyperbaric oxygen treatment (HBOT) can stimulate neuroplasticity, resulting in considerable neurological improvement and repair of chronically impaired brain functioning, as well as better quality of life in mTBI patients with long-term PCS.
Years of research have revealed that hyperbaric oxygen therapy HBOT, cryotherapy, photobiomodulation therapy, infrared sauna therapy and blood ozone therapy when used in a daily session routine, has neurotherapeutic benefits that can improve and restore cognitive brain functioning. Using iPSC technology Pure Medical are also carrying out clinical research using its lead Immunocell®. A programme that treats cognitive function with IPSCs induced pluripotent stem cell therapy.
Our bodies become less efficient in channelling oxygen as we age. This is why, as we grow older, our minds and bodies begin to “slow down.” This, however, does not have to be the case. The newest scientific study into oxygen therapy demonstrates that peak physical and mental performance can be maintained, if not regained. This research is the foundation for the Pure Medical Cognitive Healthcare Program.
Treatments & therapies Pure Medical
use to Improve Traumatic Brain Injury
Traumatic Brain Injury Treatments
Scientific Studies
In this section, you will find an array of Traumatic Brain Injury treatments scientific case studies.
Hyperbaric Oxygen Therapy (HBOT)
Boussi-Gross, R., H. Golan, G. Fishlev, Y. Bechor, O. Volkov, J. Bergan, M. Friedman, D. Hoofien, N. Shlamkovitch, E. Ben-Jacob, and S. Efrati.
RESEARCH ARTICLE – November 2013 – 0079995
Hyperbaric Oxygen Therapy (HBOT)
Kim Peterson, Donald Bourne, Johanna Anderson, Erin Boundy, and Mark Helfand
NCBI – February 2018 – NBK499535
Hyperbaric Oxygen Therapy (HBOT)
Marian McDonagh, Mark Helfand, Susan Carson, Barry S Russman
NCBI – July 2004 – PMID: 15241774
Hyperbaric Oxygen Therapy (HBOT)
Amir Hadanny, Stefanie Abbott, Gil Suzin, Yair Bechor, Shai Efrati,
BMJ. July 24, 2018 – doi: 10.1136/bmjopen-2018-023387
Hyperbaric Oxygen Therapy (HBOT)
Crawford, Cindy BA; Teo, Lynn MAOM, MS; Yang, EunMee MS; Isbister, Caitlin MS; Berry, Kevin
Journal of Head Trauma Rehabilitation. June, 2017 – doi: 10.1097/HTR.0000000000000256
Hyperbaric Oxygen Therapy (HBOT)
X Zhong, A Shan, J XU, J Liang, Y Long, B DU
Journal of International Medical Research – October 2020 – doi: 10.1177/0300060520939824
Cryotherapy
Jacob Resch
March 2018 – NLOM – NCT03185507
Cryotherapy
Ye Xiong, Asim Mahmood, and Michael Chopp
March 2010 – NCBI – PMID: 19249984
Cryotherapy
Johannes M. N. Enslin, Ursula K. Rohlwink and Anthony Figaji
February 2020 – Frontiers in Neurology – fneur.2020.00126
Blood Ozone Therapy
Bernardino Clavo, Gerardo Suarez, Yolanda Aguilar, Dominga Gutierrez, Pedro Ponce, Alberto Cubero, Francisco Robaina, Jose L Carreras
October 2013 – NCBI – PMID: 22105041
Photobiomodulation Therapy
Michael R Hamblin
April 2018 – NCBI – PMID: 29131369
Photobiomodulation Therapy
Theodore A. Henderson
April 2016 – NCBI – PMID: 27212912
Photobiomodulation Therapy
Michael R. Hamblin
December 2016 – National Library of Medicine – PMID: 27752476
Infrared Sauna Therapy
Joy Hussain and Marc Cohen
April 2018 – National Library of Medicine – PMID: 29849692
Infrared Sauna Therapy
Theodore A. Henderson
April 2016 – NCBI – PMID: 27212912
Infrared Sauna Therapy
Andrew P. Hunt, Geoffrey M. Minett, Oliver R. Gibson, Graham K. Kerr, and Ian B. Stewart
January 2020 – Frontiers in Physiology – 2019.01556
Traumatic Brain Injury
& Post Concussion
In the United Kingdom, 1.4 million people attend emergency departments in England and Wales for traumatic brain injury (TBI). TBI is one the primary cause of death and disability. TBI cases are classed as mild in 70-90 percent of cases, and up to 25% of them will not recover and experience permanent neurocognitive deficits.
Between 33% and 50% of these are children aged under 15 years. Annually, about 200,000 people are admitted to hospital with head injury. Of these, one-fifth have features suggesting skull fracture or have evidence of brain damage. Recent research has found that hyperbaric oxygen treatment (HBOT) can stimulate neuroplasticity, resulting in considerable neurological improvement and repair of chronically impaired brain functioning, as well as better quality of life in mTBI patients with long-term PCS.
Years of research have revealed that hyperbaric oxygen therapy HBOT, cryotherapy, photobiomodulation therapy, infrared sauna therapy and blood ozone therapy when used in a daily session routine, has neurotherapeutic benefits that can improve and restore cognitive brain functioning. Using iPSC technology Pure Medical are also carrying out clinical research using its lead Immunocell®. A programme that treats cognitive function with IPSCs induced pluripotent stem cell therapy.
Our bodies become less efficient in channelling oxygen as we age. This is why, as we grow older, our minds and bodies begin to “slow down.” This, however, does not have to be the case. The newest scientific study into oxygen therapy demonstrates that peak physical and mental performance can be maintained, if not regained. This research is the foundation for the Pure Medical Cognitive Healthcare Program.
Traumatic Brain Injury
Treatments & therapies Pure Medical
use to Improve Traumatic Brain Injury
Traumatic Brain Injury Treatment
Scientific Studies
In this section, you will find an array of Traumatic Brain Injury treatment scientific case studies.
Hyperbaric Oxygen Therapy (HBOT)
Boussi-Gross, R., H. Golan, G. Fishlev, Y. Bechor, O. Volkov, J. Bergan, M. Friedman, D. Hoofien, N. Shlamkovitch, E. Ben-Jacob, and S. Efrati.
RESEARCH ARTICLE – November 2013 – 0079995
Hyperbaric Oxygen Therapy (HBOT)
Kim Peterson, Donald Bourne, Johanna Anderson, Erin Boundy, and Mark Helfand
NCBI – February 2018 – NBK499535
Hyperbaric Oxygen Therapy (HBOT)
Marian McDonagh, Mark Helfand, Susan Carson, Barry S Russman
NCBI – July 2004 – PMID: 15241774
Hyperbaric Oxygen Therapy (HBOT)
Amir Hadanny, Stefanie Abbott, Gil Suzin, Yair Bechor, Shai Efrati,
BMJ. July 24, 2018 – doi: 10.1136/bmjopen-2018-023387
Hyperbaric Oxygen Therapy (HBOT)
Crawford, Cindy BA; Teo, Lynn MAOM, MS; Yang, EunMee MS; Isbister, Caitlin MS; Berry, Kevin
Journal of Head Trauma Rehabilitation. June, 2017 – doi: 10.1097/HTR.0000000000000256
Hyperbaric Oxygen Therapy (HBOT)
X Zhong, A Shan, J XU, J Liang, Y Long, B DU
Journal of International Medical Research – October 2020 – doi: 10.1177/0300060520939824
Cryotherapy
Jacob Resch
March 2018 – NLOM – NCT03185507
Cryotherapy
Ye Xiong, Asim Mahmood, and Michael Chopp
March 2010 – NCBI – PMID: 19249984
Cryotherapy
Johannes M. N. Enslin, Ursula K. Rohlwink and Anthony Figaji
February 2020 – Frontiers in Neurology – fneur.2020.00126
Blood Ozone Therapy
Bernardino Clavo, Gerardo Suarez, Yolanda Aguilar, Dominga Gutierrez, Pedro Ponce, Alberto Cubero, Francisco Robaina, Jose L Carreras
October 2013 – NCBI – PMID: 22105041
Photo-biomodulation Therapy
Michael R Hamblin
April 2018 – NCBI – PMID: 29131369
Photo-biomodulation Therapy
Theodore A. Henderson
April 2016 – NCBI – PMID: 27212912
Photo-biomodulation Therapy
Michael R. Hamblin
December 2016 – National Library of Medicine – PMID: 27752476
Infrared Sauna Therapy
Joy Hussain and Marc Cohen
April 2018 – National Library of Medicine – PMID: 29849692
Infrared Sauna Therapy
Theodore A. Henderson
April 2016 – NCBI – PMID: 27212912
Infrared Sauna Therapy
Andrew P. Hunt, Geoffrey M. Minett, Oliver R. Gibson, Graham K. Kerr, and Ian B. Stewart
January 2020 – Frontiers in Physiology – 2019.01556
